The parternship's first launch will be a vitamin D concept under MHN’s brand Selex, powered by Hologram Science’s d.velop holistic immunity platform.
Hologram Sciences (Boston), backed by Royal DSM, and Maeil Health Nutrition (MHN; Seoul, Korea) entered into a strategic partnership to deliver personalized nutrition solutions to the Korean market. Maeil will expand its offerings through a license with Hologram for its holistic immunity brand called d.velop. The parternship's first launch will be a vitamin D concept under MHN’s brand Selex, powered by Hologram Science’s d.velop holistic immunity platform. This includes easy and convenient at-home testing kits, supplementation delivery, and a digital service incorporating one-to-one coaching and actionable insights.
“We are delighted to be entering this landmark licensing partnership with MHN, our first in Asia,” said Ian Brady, CEO of Hologram Sciences, in a press release. “With their outstanding track record and leading position in functional nutrition, MHN is a perfect fit to bring our personalized health and wellness solutions to consumers in Korea.”
Hologram's d.velop leverages the ingredient ampli-D calcifediol from DSM and will be offered in a range of supplement formats. MHN will also gain access to Hologram Sciences’ other brands in the Korean market, including Phenology, a menopause-focused women's health solution.
“Personalized health and wellness is a critically important trend in our market as is the increasing need for holistic digital solutions, and we are excited to be partnering with Hologram Sciences, a true pioneer in the personalized nutrition field,” said Seon Hee Kim, CEO of Maeil Health Nutrition, in a press release. “We are already exclusive distributors of global premium food brands such as Ferrero and Arla in Korea and we look forward to working with Hologram Sciences as our exclusive health and personalized nutrition partner.”